Valneva SE (OTCPK:INRLF)
$ 2.99 -0.01 (-0.33%) Market Cap: 497.31 Mil Enterprise Value: 584.74 Mil PE Ratio: 0 PB Ratio: 2.30 GF Score: 73/100

Valneva SE R&D Investor Day Presentation Transcript

Jul 09, 2019 / 12:30PM GMT
Release Date Price: $3.72

Jul 09, 2019 / 12:30PM GMT
Presentation
Jul 09, 2019 / 12:30PM GMT

=====================
Corporate Participants
=====================
* Christian Taucher
Valneva SE - Head of Global Medical Affairs
* David Lawrence
Valneva SE - CFO & Member of Management Board
* Susanne Eder-Lingelbach
Valneva SE - Head of Clinical Operations
* Thomas Lingelbach
Valneva SE - Chairman of the Management Board, President & CEO
* Wolfgang Bender
Valneva SE - Chief Medical Officer & Member of Management Board

=====================
Conference Call Participants
=====================
* Boris Peaker
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
* Jean-Jacques Le Fur
Bryan Garnier & Co Ltd, Research Division - Analyst
* Paul Bornstein;Black Diamond Advisers;Portfolio Manager
* Stephen Douglas Willey
Stifel, Nicolaus & Company, Incorporated, Research Division - Director
* Steven James Seedhouse
Raymond James & Associates, Inc., Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot